Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
about
Time-related increase in urinary testosterone levels and stable semen analysis parameters after bariatric surgery in menKisspeptin and the hypothalamic control of reproduction: lessons from the humanThe kisspeptin-GnRH pathway in human reproductive health and diseaseLuteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight womenInsulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period.Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysisTestosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Body weight impact on puberty: effects of high-calorie diet on puberty onset in female rhesus monkeys.Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.Effects of sericin on the testicular growth hormone/insulin-like growth factor-1 axis in a rat model of type 2 diabetes.Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.Kisspeptins in human reproduction-future therapeutic potentialEffect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in ratsNegative effects of high glucose exposure in human gonadotropin-releasing hormone neurons.Metabolic influences on neuroendocrine regulation of reproduction.The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism.Current and future applications of GnRH, kisspeptin and neurokinin B analogues.Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery-A Comprehensive Review.Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism.Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.The interaction of fasting, caloric restriction, and diet-induced obesity with 17β-estradiol on the expression of KNDy neuropeptides and their receptors in the female mouse.Clinical and biochemical correlates of male hypogonadism in type 2 diabetes.Effects of Orchidectomy and Testosterone Replacement on Numbers of Kisspeptin-, Neurokinin B-, and Dynorphin A-Immunoreactive Neurones in the Arcuate Nucleus of the Hypothalamus in Obese and Diabetic Rats.
P2860
Q24170158-929AAD50-D1D6-4265-8363-1541DC603787Q26830026-8676970A-B0E1-4051-83C1-B340A68C776DQ28235672-CCDB8145-5FC9-45A6-8555-FA304E2C1C2AQ28391267-2E67588F-3512-4F51-8ED8-0B643A81718DQ30405254-CF645DE2-7C3F-43F2-B94D-51A5805668B2Q33610868-7AD2BB20-2360-4E81-A285-B8CBE1BBB693Q35810322-B1741ED8-32D0-4292-875F-B80C884A1810Q35872759-4DBD75D7-6D33-49CF-A3C5-875B21E2437AQ35876203-C478BEF3-1A0B-4130-B9B4-B0D482F0BD2FQ36046065-46D5EF49-6252-40B9-9B55-65004337A2D5Q36248549-2995A23C-C8E7-4ED8-B3DE-6615F8405C9CQ36381611-1234EA67-2282-4C61-B794-528E0432969FQ36629106-174F35BF-9CD7-4FB0-A06B-84B93C6AE80BQ37486480-FB32C67B-4889-477A-8BD2-D5FA98C49BCFQ37504493-6B701EAA-4961-4F50-822F-881606573FFEQ38057355-CE345640-FA99-4EF1-A91D-499B16AFCE8DQ38118569-8BFA5242-CD6D-4F71-A199-CB7428D0FAE2Q38429957-37013A23-F76D-4691-AF40-327711C672A8Q45359713-DCBDD759-E7BC-461B-B4FE-05C4C9D0F862Q46304482-AF0D83E5-8AD1-4BF0-BB55-76649A71B5F1Q48026896-A9E5413B-65CD-4BA2-B77F-5E313A6A8377Q48289660-D5322BBE-EE51-4302-9307-7D36C44C7ADEQ52810468-305B9A17-ACAF-49CC-B8F3-D6DAF5AA0786
P2860
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@en
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@nl
type
label
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@en
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@nl
prefLabel
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@en
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@nl
P921
P356
P1433
P1476
Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
@en
P2093
Richard A Anderson
P304
P356
10.1159/000299767
P577
2010-06-10T00:00:00Z